Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
Back to event

Watch: Where Do Our Generic Drugs Come From? We Dug to Find Out.

By Katie Nixdorf · Nov 9, 2026, 9:55 AM CST

Read full article at ProPublica
These days, we know where almost everything comes from. Everyday items like food, clothes and pens all carry labels listing where things are grown, manufactured or even designed. So why is it so hard to find where prescription drugs are made? That question set off a 14-month investigation into where our medications are made, how the FDA polices drug manufacturers and what happens when inspectors r

Excerpt shown under fair-use limits. Full text remains with the original publisher.

People in this coverage

Explore their history and attributable record. Being mentioned does not imply endorsement.

Layer 1 · Claims & fact checks

AI analysis

Layer 2 · Biblical perspective

Biblical interpretation
UNHOLY / UNRIGHTEOUS
Read the biblical analysis

Layer 3 · Reporting analysis

AI analysis

AnecdoteUses a personal tragedy to illustrate potential harms, creating an emotional appeal.

Sensational languageVivid, graphic descriptions are employed to provoke fear about drug safety.

Authority appealCites official FDA statements to lend credibility while also highlighting lack of detail.

Call to actionEncourages reader engagement with the Rx Inspector tool, positioning it as a solution.

Context

AI analysis

Missing context

The article does not provide quantitative data on how many generic‑drug facilities have been inspected, the overall rate of compliance violations, or the specific criteria the FDA uses to grant exemptions to banned factories. It also lacks broader context about the total volume of generic drugs imported versus domestically produced and the regulatory safeguards in place for drug safety beyond the anecdotal examples.

Important context

The piece notes that the FDA’s inspection reports are often redacted for commercial confidentiality, that the agency claims exemptions are "thoroughly evaluated through a multi‑disciplinary approach," and that drug companies assert they adhere to quality standards. It also explains that the Rx Inspector tool is limited by the completeness of FDA data and is not medical advice.

Opinion vs. reporting

AI analysis

The article primarily reports findings from the investigation, citing interviews, lab tests, and FDA statements, but it also incorporates emotive anecdotes (e.g., the transplant patient’s death) and language that heightens concern, which blurs the line between straight reporting and persuasive storytelling.